AR and breast carcinoma: Correlation of AR expression with standard clinical pathological factors and clinical outcomes of interest were assessed; including disease free survival (DFS), breast cancer specific survival (BCSS), and overall survival (OS).<h4>Results</h4>149 patients with non-metastatic TNBC were included.